AstraZeneca to Buy Fusion Pharma for Up to $2.4 Billion
AstraZeneca Plc agreed to buy Fusion Pharmaceuticals Inc. for as much as $2.4 billion as it seeks to transform cancer…
64,000€
-0,39%
Echtzeit-Aktienkurs Astrazeneca PLC (Spons. ADRs)
Bid:
Ask:
Nachrichten zur Astrazeneca PLC (Spons. ADRs) Aktie
AstraZeneca to buy Fusion Pharma for $2 billion in cash By Reuters
AstraZeneca to buy Fusion Pharma for $2 billion in cash…
AstraZeneca to acquire Fusion
19 March 2024
AstraZeneca to acquire Fusion to accelerate the development of
next-generation radioconjugates to treat cancer
Includes actinium-based clinical-stage radioconjugate targeting PSMA…
AstraZeneca caps inhaler costs at $35 for eligible US patients By Investing.com
AstraZeneca caps inhaler costs at $35 for eligible US patients…
AstraZeneca to cap US out-of-pocket costs for inhalers at $35 per month By Reuters
AstraZeneca to cap US out-of-pocket costs for inhalers at $35 per month…